Abbvie Inc (ABBV) Monthly Backtest Results
Backtest Summary
This table summarises how profitable it would have been to have bought this stock at each monthly entry signal. The compound annual growth rate (CAGR) shows the profitability of the trade on an annualised basis.
| Entry Date | Exit Date | Profit or Loss | CAGR |
|---|---|---|---|
| 01 October 2025 | Trade in progress | -5.91% | |
| 03 March 2025 | 02 June 2025 | -11.56% | -38.92% |
| 01 February 2024 | 02 January 2025 | 8.09% | 8.82% |
| 03 April 2023 | 01 June 2023 | -18.21% | -71.17% |
| 01 December 2022 | 01 February 2023 | -9.11% | -43.02% |
| 01 December 2021 | 01 September 2022 | 17.87% | 24.48% |
| 04 January 2021 | 01 October 2021 | 2.23% | 3.03% |
| 01 June 2020 | 02 November 2020 | -4.64% | -10.7% |
| 02 December 2019 | 01 April 2020 | -15.66% | -40.18% |
| 03 January 2017 | 02 July 2018 | 55.89% | 34.63% |
| 02 May 2016 | 01 November 2016 | -6.33% | -12.29% |
| 01 December 2015 | 01 February 2016 | -6.39% | -32.21% |
| Total Return | 6.28% | ||
The monthly data for Abbvie Inc (exchange: XNYS symbol: ABBV) was last updated 27 Dec 2025 05:21. Data for this stock is available from 01 Sep 2015 - 26 Dec 2025.
